Electrophysiological features of chronic inflammatory demyelinating polyradiculoneuropathy associated with IgG4 antibodies targeting neurofascin 155 or contactin 1 glycoproteins

Attarian, 2001, Terminal latency index and modified F ratio in distinction of chronic demyelinating neuropathies, Clin Neurophysiol, 112, 457, 10.1016/S1388-2457(01)00469-2 Boyle, 2001, Contactin orchestrates assembly of the septate-like junctions at the paranode in myelinated peripheral nerve, Neuron, 30, 385, 10.1016/S0896-6273(01)00296-3 Delmont, 2016, Motor unit number index (MUNIX): Is it relevant in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)?, Clin Neurophysiol, 127, 1891, 10.1016/j.clinph.2015.12.002 Delmont, 2017, Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy, Brain, 140, 1851, 10.1093/brain/awx124 Devaux, 2016, Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy, Neurology, 86, 800, 10.1212/WNL.0000000000002418 Doppler, 2016, Auto-antibodies to contactin-associated protein 1 (Caspr) in two patients with painful inflammatory neuropathy, Brain, 139, 2617, 10.1093/brain/aww189 Doppler, 2015, Destruction of paranodal architecture in inflammatory neuropathy with anti-contactin-1 autoantibodies, J Neurol Neurosurg Psychiatry., 86, 720, 10.1136/jnnp-2014-309916 Garg, 2017, Neurofascin-155 IGG4 neuropathy: pathophysiological insights, spectrum of clinical severity and response to treatment, Muscle Nerve, 57, 848, 10.1002/mus.26010 Graham, 2006, A modified peripheral neuropathy scale: the Overall Neuropathy Limitations Scale, J Neurol Neurosurg Psychiatry., 77, 973, 10.1136/jnnp.2005.081547 Hashimoto, 2018, Chronic inflammatory demyelinating polyneuropathy with concurrent membranous nephropathy: an anti-paranode and podocyte protein antibody study and literature survey, Front Neurol, 9, 1 Joint Task Force of the EFNS and the PNS. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripher. J Peripher Nerv Syst 2010;15(3):185–95. Kadoya, 2016, IgG4 anti-neurofascin155 antibodies in chronic inflammatory demyelinating polyradiculoneuropathy: clinical significance and diagnostic utility of a conventional assay, J Neuroimmunol, 301, 16, 10.1016/j.jneuroim.2016.10.013 Koike, 2017, Paranodal dissection in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin-155 and anti-contactin-1 antibodies, J Neurol Neurosurg Psych, 88, 465, 10.1136/jnnp-2016-314895 Manso, 2019, Anti–neurofascin-155 IgG4 antibodies prevent paranodal complex formation in vivo, J Clin Invest, 129, 2222, 10.1172/JCI124694 Manso, 2016, Contactin-1 IgG4 antibodies cause paranode dismantling and conduction defects, Brain, 139, 1700, 10.1093/brain/aww062 Miura, 2015, Contactin 1 IgG4 associates to chronic inflammatory demyelinating polyneuropathy with sensory ataxia, Brain, 138, 1484, 10.1093/brain/awv054 Ng JKM, Malotka J, Kawakami N, Derfuss T, Khademi M, Olsson T, et al. Neurofascin as a target for autoantibodies in peripheral neuropathies. Neurology. Institute of Clinical Neuroimmunology, Ludwig Maximilians University, Munich, Germany; 2012;79(23):2241–8. Ogata, 2015, Characterization of IgG4 anti-neurofascin 155 antibody-positive polyneuropathy, Ann Clin Transl Neurol, 2, 960, 10.1002/acn3.248 Querol, 2014, Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg, Neurology, 82, 879, 10.1212/WNL.0000000000000205 Querol, 2013, Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy, Ann Neurol, 73, 370, 10.1002/ana.23794 Rajabally, 2012, A European multicentre reappraisal of distal compound muscle action potential duration in chronic inflammatory demyelinating polyneuropathy, Eur J Neurol, 19, 638, 10.1111/j.1468-1331.2011.03605.x Sherman, 2005, Neurofascins are required to establish axonal domains for saltatory conduction, Neuron, 48, 737, 10.1016/j.neuron.2005.10.019 Susuki, 2007, Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers, J Neurosci, 27, 3956, 10.1523/JNEUROSCI.4401-06.2007 Taieb, 2018, “Neuro-renal syndrome” related to anti-contactin-1 antibodies, Muscle Nerve, 59, E19 Uncini, 2013, Nodo-paranodopathy: Beyond the demyelinating and axonal classification in anti-ganglioside antibody-mediated neuropathies, Clin Neurophysiol, 124, 1928, 10.1016/j.clinph.2013.03.025 Vallat, 2017, Paranodal lesions in chronic inflammatory demyelinating polyneuropathy associated with anti-neurofascin 155 antibodies, Neuromuscul Disord, 27, 290, 10.1016/j.nmd.2016.10.008